Does $2.44 justifies Rite Aid Corporation (RAD) shares?

Does $2.44 justifies Rite Aid Corporation (RAD) shares?

Andrew Cummings
September 21, 2017

(NASDAQ:WBA) trade at $80.64 by moved down -0.70% in most recent trading session with share volume of 729187. Finally, Webster Bank N.A. raised its holdings in shares of Walgreens Boots Alliance by 18.4% during the first quarter. Reilly Financial Advisors LLC increased its position in shares of Walgreens Boots Alliance by 7.9% in the second quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator's stock worth $113,000 after acquiring an additional 1,006 shares in the last quarter. IBM Retirement Fund boosted its stake in Walgreens Boots Alliance by 88.1% through out the 2nd period. Richard C. Young & CO. Moreover, Riverbridge Partners Llc has 2.53% invested in the company for 1.97 million shares. (WBA) average trading volume of 6,013,390 during the past month is 33.04% above its average volume over the past year, indicating that investors have been more active than usual in the stock in recent times.

WBA has been the topic of a number of recent research reports. Robert W. Baird initiated Walgreens Boots Alliance Inc (NASDAQ:WBA) on Friday, January 22 with "Outperform" rating.

Analysts expect Walgreens Boots Alliance Inc (NASDAQ:WBA) to report $1.22 EPS on October, 19.They anticipate $0.15 EPS change or 14.02% from last quarter's $1.07 EPS. The stock of Walgreens Boots Alliance Inc (NASDAQ:WBA) earned "Outperform" rating by Credit Suisse on Monday, July 18. About shares traded. Walgreens Boots Alliance Inc (NASDAQ:WBA) has risen 5.77% since September 20, 2016 and is uptrending.

Walgreens Boots Alliance (NASDAQ:WBA) opened at 81.21 on Friday.

The consensus recommendation - averaging the work of 26 analysts - of 2 for Walgreens Boots Alliance, Inc. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and fifteen have issued a buy rating to the company's stock. The company now has an average rating of "Hold" and a consensus price target of $4.08.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was copied illegally and reposted in violation of USA and worldwide copyright law. The correct version of this piece can be accessed at After having $1.33 EPS previously, Walgreens Boots Alliance Inc's analysts see -8.27% EPS growth. (NASDAQ:WBA) has been trading in a bearish manner, based on the relative positions of the stock's 20 and 200 day moving averages.

Shares of Walgreens Boots Alliance, Inc. This is assuming the current $1.22 EPS is accurate. Comerica Bank stated it has 0% in Rite Aid Corporation (NYSE:RAD).

On its own, lowering RAD debt is probably enough to bring the stock higher because the firm's quarterly reports will likely start to look a little more solid without the $432 million in interest expense that the firm has been running up each year. Zacks upgraded it to "Hold" rating and $98 target in Tuesday, September 1 report.

The company is now down since yesterday's close of 81.21. Stock analysts expect that Walgreens Boots Alliance to post $5.00 EPS for the present financial year. The company was maintained on Thursday, June 29 by Pivotal Research. This repurchase authorization permits the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. While past twelve months price to sales ratio recorded as 0.25 and price to cash ratio remained 12.03. The dividend was $0.400 per share for the quarter or $1.60 on an annualized basis. The ex-dividend date was Wednesday the 16th of August 2017. This dividend amount was represent a yield of $1.94. Walgreens Boots Alliance's dividend payout ratio is 40.30%. Reilly Advsrs Ltd Liability reported 2,994 shares or 0.06% of all its holdings. The total value of its holdings increased 35,551.9%. Following the transaction, the director now owns 19,151 shares in the company, valued at approximately $1,528,058.29. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The Company's divisions include Personal Care, Consumer Tissue, K-C Professional and Corporate & Other. They issued a "hold" rating and a $2.50 price objective for the company. The Company is a pharmacy-led health and wellbeing company. The company has market cap of $86.90 billion.

Other reports by iNewsToday